PRGX Demonstrates How Retailers Can Reinvent Recovery Audits with a Preventive Approach
ATLANTA, June 08, 2020 (GLOBE NEWSWIRE) — PRGX Global, Inc. (Nasdaq: PRGX), a global leader in Recovery Audit and Spend […]
Pzena Investment Management, Inc. Announces May 31, 2020 Assets Under Management
NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — Pzena Investment Management, Inc. (NYSE: PZN) today reported its preliminary assets under […]
UPS Calls For Justice And Reform To Advance Equality
ATLANTA, June 08, 2020 (GLOBE NEWSWIRE) —Urges Immediate Passage of Federal Antilynching Act and State-BasedHate Crime Bills, including Georgia’sProvides $3.2 […]
O-I Glass Second Quarter 2020 Business Update
PERRYSBURG, Ohio, June 08, 2020 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) today provided a business update in advance […]
Replimune Announces Proposed Public Offering
BOSTON, June 08, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived […]
Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update
NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence […]
Monroe Capital Corporation BDC Announces Change of 2020 Annual Meeting of Stockholders to Virtual Format
CHICAGO, June 08, 2020 (GLOBE NEWSWIRE) — Monroe Capital Corporation (Nasdaq: MRCC) (“Monroe”) announced today that, due to the COVID-19 […]
Oil-Dri Announces Third Quarter and First Nine-Months of Fiscal 2020 Results
CHICAGO, June 08, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, […]
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for […]
GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor) to Treat Children Ages 4 to 11 Years with Sickle Cell Disease
New Drug Application submission, including new age-appropriate formulation, planned by mid-2021SOUTH SAN FRANCISCO, Calif., June 08, 2020 (GLOBE NEWSWIRE) — […]
